The new entity will leverage TriNetX's LIVE platform, which encompasses a network of 200 million patient records.

TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu, a ...

Although Stelara and Entyvio demonstrated similar cardiovascular safety profiles among older patients with inflammatory bowel ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

A newly released economic impact analysis conducted by the Connecticut Center for Economic Analysis (CCEA) at the University of Connecticut and jointly commissioned by Connecticut Sports Group and ...

Pathify, a leading digital engagement hub for higher education, today announced it has raised $25 million in a minority investment from Five Elms Capital, a leading software investment ...

Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Women prescribed a GLP-1 receptor agonist up to 2 years before conception were less likely to develop hypertensive disorders ...

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.

The use of biologics in psoriasis and psoriatic arthritis management is not linked to the risk of cardiovascular or venous thromboembolic events.

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.